SSB
CRBP icon

Sandy Spring Bank’s Corbus Pharmaceuticals CRBP Stock Holding History

Sandy Spring Bank’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1
Closed -$12 – 1239
2024
Q4 		$12 Hold
1
– – ﹤0.01% 1204
2024
Q3 		$21 Hold
1
– – ﹤0.01% 1190
2024
Q2 		$45 Hold
1
– – ﹤0.01% 1254
2024
Q1 		$39 Hold
1
– – ﹤0.01% 1226
2023
Q4 		$6 Hold
1
– – ﹤0.01% 1175
2023
Q3 		$7 Hold
1
– – ﹤0.01% 1182
2023
Q2 		$8 Hold
1
– – ﹤0.01% 1223
2023
Q1 		$7 Sell
1
-1
-50% -$4 ﹤0.01% 1157
2022
Q4 		$6 Buy
+2
New +$8 ﹤0.01% 1142

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EAM
Exome Asset Management New York $193M AUM 208.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Sandy Spring Bank's CRBP Position: Q1 2025 in Review

Sandy Spring Bank sold out of Corbus Pharmaceuticals (CRBP) in Q1 2025, closing a stake of 1 share — an estimated $12 sold.

Sandy Spring Bank first reported a position in CRBP in Q4 2022 and held it in 9 quarters. The position peaked at $45 in Q2 2024. 86 funds tracked by Wall St. Rank hold CRBP as of Q1 2025.

  • Sandy Spring Bank reported no remaining Corbus Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Sandy Spring Bank sold 1 Corbus Pharmaceuticals share in Q1 2025, an estimated $12.
  • Sandy Spring Bank first reported a position in Corbus Pharmaceuticals in Q4 2022 and held it in 9 quarters.
  • Sandy Spring Bank's Corbus Pharmaceuticals position peaked at $45 in Q2 2024.
  • 86 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2025.

Based on Sandy Spring Bank's 13F filing for Q1 2025, filed 12 May 2025.